Hopp til innhold
NHI.no
Annonse

Tvangslidelse: Årsaker

Innhold i artikkelen

Årsaksforholdene er sannsynligvis sammensatte, og både arvelige, biologiske og psykologiske faktorer bidrar til utvikling av lidelsen. Grensene mellom egentlige årsakssammenhenger, forhold som oppstår som følge av tvangslidelse og utløsende faktorer er ikke veldefinerte. Mye tyder på at tvangslidelse er en utviklingsmessig forstyrrelse i sentralnervesystemet. Det synes å være en ubalanse i impulsoverføringene mellom ulike deler av hjernen. Dette fremmer dysfungerende handlinger. Ved behandling med antidepressiva (SSRI) og atferdsterapi er det sett normalisering av disse misforholdene.

Annonse

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Tvangslidelse . Referanselisten for dette dokumentet vises nedenfor

  1. Jenike MA. Obsessive-compulsive disorder. N Engl J Med 2004; 350: 259-65. PubMed
  2. Heymann I, Mataix-Cols D, Fineberg NA. Obsessive-compulsive disorder. BMJ 2006; 333: 424-9. PubMed
  3. Fenske JN, Petersen K. Obsessive-compulsive disorder: diagnosis and management. Am Fam Physician. 2015 Nov 15;92(10):896-903. pmid: 26554283 PubMed
  4. Ruscio AM, Stein DJ, Chiu WT, Kessler RC. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry. 2010;15(1):53–63. pmid: 18725912 PubMed
  5. Wittchen HU, Jacobi F. Size and burden of mental disorder in Europe: a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol 2005; 15: 357-76. PubMed
  6. Heyman I, Fombonne E, Simmons H, Ford T, Meltzer H, Goodman R. Prevalence of obsessive-compulsive disorder in the British nationwide survey of child mental health. Br J Psychiatry 2001; 179: 324-9. pmid: 12745330 PubMed
  7. Pauls DL, Abramovitch A, Rauch SL, Geller DA. Obsessive-compulsive disorder. Nat Rev Neurosci. 2014;15(6):410–424. pmid: 24840803 PubMed
  8. Becker Nissen JB, Mikkelsen HU, Thomsen PH. Den neurobiologiske baggrund for obsessiv kompulsiv forstyrrelse. Ugeskr Læger 2005; 167: 34-7. PubMed
  9. Pallanti S, Quercioli L. Treatment-refractory obsessive-compulsive disorder: methodological issues, operational definitions and therapeutic lines. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:400-412. PubMed
  10. Pinto A, Mancebo MC, Eisen JL, et al. The Brown Longitudinal Obsessive Compulsive Study. J Clin Psychiatry. 2006;67(5):703–711. pmid: 16841619 PubMed
  11. Torres AR, Ramos-Cerqueira AT, Ferrão YA, et al. Suicidality in obsessive-compulsive disorder. J Clin Psychiatry. 2011;72(1):17–26. pmid: 21272513 PubMed
  12. Fineberg NA, et al. Clinical screening for obsessive-compulsive and related disorders. Isr J Psychiatry Relat Sci. 2008;45(3):151–163. pmid: 19398819 PubMed
  13. Öst LG, Havnen A, Hansen B, Kvale G. Cognitive behavioral treatments of obsessive-compulsive disorder. A systematic review and meta-analysis of studies published 1993-2014. Clinical Psychology Review, 2015; 40: 156–169. doi:10.1016/j.cpr.2015.06.003 DOI
  14. Diedrich A, Voderholzer U. Obsessive-compulsive personality disorder: a current review. Curr Psychiatry Rep. 2015 Feb;17(2):2. pmid: 25617042 PubMed
  15. Olatunji BO, Davis ML, Powers MB, et al. Cognitive-behavioral therapy for obsessive-compulsive disorder: a meta-analysis of treatment outcome and moderators. J Psychiatr Res. 2013 Jan;47(1):33-41. DOI: 10.1016/j.jpsychires.2012.08.020. DOI
  16. Pediatric OCD Treatment Study (POTS) Team. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the pediatric OCD treatment study (POTS) randomized controlled trial. JAMA 2004; 292: 1969-76. pmid: 15507582 PubMed
  17. Foa EB, Franklin ME, Moser J. Context in the clinic: how well do cognitive-behavioral therapies and medications work in combination? Biol Psychiatry 2002;52:987-997. PubMed
  18. Rosa-Alcázar AI, et al. Psychological treatment of obsessive-compulsive disorder. Clin Psychol Rev. 2008;28(8):1310–1325. pmid: 18701199 PubMed
  19. Gava I, Barbui C, Aguglia E, et al. Psychological treatment versus treatment as usual for obsessive compulsive disorder (OCD). Cochrane Database of Systematic Reviews, issue 2, 2007. CD005333.pub2 Cochrane (DOI)
  20. Hansen B, Kvale G, Hagen K, Havnen A, Öst LG. The Bergen 4-day treatment for OCD: four years follow-up of concentrated ERP in a clinical mental health setting. Cogn Behav Ther 2018. www.tandfonline.com
  21. Barrett P, Healy-Farrell L, March JS. Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: a controlled trial. J Am Acad Child Adolesc Psychiatry 2004; 43: 46-62. PubMed
  22. Simpson HB. Pharmacotherapy for obsessive-compulsive disorder in adults. UpToDate, last updated Jun 22, 2017. www.uptodate.com
  23. Andersson E, Enander J, Andrén P, et al. Internet-based cognitive behaviour therapy for obsessive-compulsive disorders: a randomized controlled trial. Psychological Medicine 2012; pmid: 22348650 PubMed
  24. Hirschtritt ME, Bloch MH, Mathews CA. Obsessive-Compulsive Disorder Advances in Diagnosis and Treatment. JAMA 2017; 317(13): 1358-67. doi:10.1001/jama.2017.2200 DOI
  25. Soomro GM, Altman D, Rajagopal S, Oakley-Browne M. Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD). Cochrane Database Syst Rev. 2008;(1):CD001765. Cochrane (DOI)
  26. Koran LM, Hackett E, Rubin A, Wolkow R, Robinson D. Efficacy of sertraline in the long term treatment of obsessive-compulsive disorder. Am J Psychiatry 2002; 159: 89-95. pmid: 11772695 PubMed
  27. Koran LM, et al. Practice guideline for the treatment of patients with obsessive-compulsive disorder. Am J Psychiatry. 2007;164(7 suppl):5–53. pmid: 17849776 PubMed
  28. Fineberg NA, et al. Evidence-based pharmacotherapy of obsessive-compulsive disorder. Int J Neuropsychopharmacol. 2012;15(8):1173–1191. pmid: 22226028 PubMed
  29. Berlim MT, Neufeld NH, Van den Eynde F. Repetitive transcranial magnetic stimulation (rTMS) for obsessive-compulsive disorder (OCD): an exploratory meta-analysis of randomized and sham-controlled trials. J Psychiatr Res. 2013 Aug;47(8):999-1006. PubMed
  30. Ravizza L, Maina G, Bogetto F. Episodic and chronic obsessive-compulsive disorder. Depress Anxiety 1997; 6: 154-8. PubMed
  31. Baldwin DS, Anderson IM, Nutt DJ, et al. Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology. J Psychopharmacol. 2014 May;28(5):403-39. PubMed
Annonse
Annonse